IREN Drops 18% as $30B AI Spending Plan Triggers Financing Fears

What happened

IREN shares fell 18% over the past week, erasing gains built on booming AI demand, as investors balked at a proposed $30 billion spending plan that would sharply increase capital intensity. The sell-off occurred even though AI computing demand remains strong and the company recently achieved first customer acceptance of its Horizon 1 GPU capacity. The market's reaction aligns with the master report's warning that financing and execution risk, not demand, now govern the stock's trajectory. With cash and restricted cash of $7.62 billion against prior commitments of $13.81 billion, a $30 billion plan would likely force further equity or debt issuance, threatening per-share economics. The stock is now trading below the master report's $40 attractive-entry threshold, potentially shifting the risk-reward for investors willing to accept milestone uncertainty.

Implication

Investors should treat the pullback as a conditional opportunity rather than an automatic buy, because the new $30B spend plan likely extends the dilution runway and increases sensitivity to credit markets. The key trigger for a positive re-rating remains acceptance of Microsoft Horizons 2-4 by year-end, which would validate revenue conversion and potentially lower financing costs. Until then, the stock may remain range-bound as the market weighs near-term AI revenue growth against ballooning capex and a projected net loss of $702.6M for FY2026. A move below $38 (the bear-case implied value) would likely reflect actual execution or financing deterioration, while a stabilization above $40 with clear acceptance news could support a more constructive stance. For now, holding a partial position with a stop below $35 and adding only on evidence of disciplined funding is prudent.

Thesis delta

The master report rated IREN a WAIT with an attractive entry at $40 and a trim above $56, but the new $30B spending plan materially raises financing risk and could push the stock toward the bear case of $38 if markets price in higher dilution. The drop to below $40 now meets the technical entry condition, yet the increased capital intensity without confirmed funding discipline prevents a rating upgrade to BUY until acceptance milestones or favorable financing terms appear. Consequently, the thesis shifts to a more defensive WAIT, with investors urged to demand a larger margin of safety given the widened uncertainty.